![](https://www.diabetesnews.com/wp-content/uploads/2014/02/FDA-Logo-150x150.jpg)
The injectable medication, originally prescribed to treat wet macular degeneration ( a disease of the eye that results in a loss of vision at the center of the field of vision when blood vessels abnormally leak fluid into the macula ) was approved for expanded use in late July.